UBE2K and Alzheimer disease: We further investigated the downstream targets of UBE2K in mediating synaptic impairment in AD, and found that GluN2B, a subunit of N-methyl-D-aspartate (NMDA) receptor essential for neuronal communication [27], may be its target.